Your browser doesn't support javascript.
loading
JAK2 regulates paclitaxel resistance in triple negative breast cancers.
Han, Jongmin; Yun, Jihui; Quan, Mingji; Kang, Wonyoung; Jung, Ji-Gwang; Heo, Woohang; Li, Songbin; Lee, Kyu Jin; Son, Hye-Youn; Kim, Ju Hee; Choi, Jaeyong; Noh, Dong-Young; Na, Deukchae; Ryu, Han Suk; Lee, Charles; Kim, Jong-Il; Moon, Hyeong-Gon.
Afiliação
  • Han J; Interdisciplinary Graduate Program in Cancer Biology, Seoul National University College of Medicine, Seoul, Korea.
  • Yun J; Medical Research Center, Genomic Medicine Institute, Seoul National University, Seoul, Korea.
  • Quan M; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
  • Kang W; Interdisciplinary Graduate Program in Cancer Biology, Seoul National University College of Medicine, Seoul, Korea.
  • Jung JG; The Jackson Laboratory of Genomic Medicine, Farmington, CT, USA.
  • Heo W; Department of Life Sciences, Ewha Womans University, Seoul, Korea.
  • Li S; Department of Surgery, Seoul National University Hospital, Seoul, Korea.
  • Lee KJ; Interdisciplinary Graduate Program in Cancer Biology, Seoul National University College of Medicine, Seoul, Korea.
  • Son HY; Interdisciplinary Graduate Program in Cancer Biology, Seoul National University College of Medicine, Seoul, Korea.
  • Kim JH; Interdisciplinary Graduate Program in Cancer Biology, Seoul National University College of Medicine, Seoul, Korea.
  • Choi J; Center for Medical Innovation, Seoul National University Hospital, Seoul, Korea.
  • Noh DY; Center for Medical Innovation, Seoul National University Hospital, Seoul, Korea.
  • Na D; Medical Research Center, Genomic Medicine Institute, Seoul National University, Seoul, Korea.
  • Ryu HS; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
  • Lee C; Department of Surgery, Seoul National University Hospital, Seoul, Korea.
  • Kim JI; Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
  • Moon HG; Cancer Research Institute, Seoul National University, Seoul, Korea.
J Mol Med (Berl) ; 99(12): 1783-1795, 2021 12.
Article em En | MEDLINE | ID: mdl-34626199
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paclitaxel / Resistencia a Medicamentos Antineoplásicos / Janus Quinase 2 / Neoplasias de Mama Triplo Negativas / Neoplasias Mamárias Experimentais / Antineoplásicos Fitogênicos Limite: Animals / Female / Humans Idioma: En Revista: J Mol Med (Berl) Assunto da revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paclitaxel / Resistencia a Medicamentos Antineoplásicos / Janus Quinase 2 / Neoplasias de Mama Triplo Negativas / Neoplasias Mamárias Experimentais / Antineoplásicos Fitogênicos Limite: Animals / Female / Humans Idioma: En Revista: J Mol Med (Berl) Assunto da revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Ano de publicação: 2021 Tipo de documento: Article